jRCTs051180233已完成不适用
Phase II study of multidisciplinary therapy of pediatric intracranial ependymoma with risk classification by postoperative residual tumor size and histological malignancy. (JCCG EPN1501)
未提供0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 3age old over 至 20age old not（—）
- 性别
- All
入选标准
- •Newly developed intracranial ependymoma, from 3 years old to under 20 years old (no seeding metastatic lesions)
排除标准
- •Exclude those subject to any of the following conditions.
- •Active duplication cancers (simultaneous duplicated cancers and metachronous duplicated cancers with disease-free period within 5 years).
- •Heart disease with treatment is merged.
- •Pregnant or lactating women
- •When judging that the doctor in charge is inappropriate
结局指标
主要结局
-
Progression-free survival rate (PFS) in 2 years, 5 years, and 7 years
次要结局
- 2-year progression-free survival rate(2-year)
- 2-year overall survival rate(2-year)
研究者
相似试验
已完成
不适用
Adult Intracranial EpendymomaIntracranial EpendymomaNCT00920335Assistance Publique Hopitaux De Marseille192
已完成
1 期
MGMT Gene Therapy and Chemotherapy for the treatment of Childhood Brain TumoursChildhood Brain TumoursCancer - BrainACTRN12612000535875The Sydney Children's Hospital Network12
招募中
不适用
Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsEpendymoma of BrainPediatric Solid TumorNCT05151718Institut Claudius Regaud370
招募中
不适用
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.Medulloblastoma, WNT-activatedNCT04474964Tata Memorial Centre30
已完成
1 期
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaNeuroblastomaNCT00644696University of Michigan Rogel Cancer Center18